Stay updated with breaking news from General Plastic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the institution decision for Mylan Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., IPR2022-01225, Paper 21 (P.T.A.B. Jan. 11, 2023), the Patent Trials & Appeals Board ("the Board")...
2022 was a milestone year for the Patent Trial and Appeal Board. In April, Kathi Vidal began her tenure as Director of the United States Patent and Trademark Office with an early focus...
The latest instalment of the IAM-Docket Navigator US patent litigation special report puts the magnifying glass to data on discretionary denials
I enjoy all aspects of patent law and am always happy to get involved in all kinds of different matters, ranging from district court and ITC litigation, to PTAB proceedings.
The ongoing battle over the proper remedy for Patent Trial and Appeal Board (PTAB) petitioner misconduct took a dramatic turn this past week.